023910.KQ
Daihan Pharmaceutical Co.,Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 27,250.00
+1.49%Margins
Gross margin
29.5%
EBITDA margin
20.0%
EBIT margin
13.9%
Net margin
12.7%
FCF margin
9.3%
8.9%
Return on equity
7.7%
Return on assets
9.8%
Return on invested capital
0.61x
Asset turnover
KRW 37.3B
Cash from operations
KRW 19.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026